Regulation by Proteolysis-Independent Ubiquitination

不依赖蛋白水解的泛素化调节

基本信息

  • 批准号:
    8704948
  • 负责人:
  • 金额:
    $ 42.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-08-01 至 2016-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Ubiquitylation, the covalent attachment of the small protein ubiquitin to other proteins, regulates a host of cellular processes. Protein ubiquitylation has become a synonym for protein degradation, and most of the current research is focused on the role of ubiquitin in targeting proteins for degradation by the 26S proteasome. However, we are beginning to appreciate that a number of proteins are regulated by ubiquitylation in a proteolysis-independent manner. Recent system-wide experiments suggest that only little more than fifty percent of ubiquitylated proteins are efficiently degraded by the proteasome, implying that protein ubiquitylation has widespread signaling functions outside the proteasome pathway. Molecular understanding of these proteolysis-independent ubiquitin signals will be important for basic biomedical research and development of therapeutics targeting the ubiquitin system. Some of the key questions are: Why are some ubiquitylated proteins degraded and others are not? How can ubiquitylation directly affect protein activity? What are the mechanisms of direct protein regulation by ubiquitylation and what are the components mediating regulation? We analyze a system regulated by the cullin-RING ubiquitin ligase complex SCFMet30, which connects metabolic stress to cell cycle regulation. This pathway is particularly suited to probe non-proteolytic signals of ubiquitylation because the same ligase modifies different substrate proteins with the same lysine-48 linked ubiquitin chain, yet some substrates are labeled for degradation while other substrates are regulated in a proteolysis-independent manner. This proposal builds on a plethora of tools available to analyze biochemistry and physiology of this pathway and will address (i) how regulated ubiquitin-binding domains can dictate signal identity and switch between ubiquitin chains signaling for degradation and non-proteolytic regulation (Aim 1); (ii) how a polyubiquitin chain can directly regulate transcription factor activity (Aim 2) and (iii) how ubiquitylation induces active disassembly/remodeling of multisubunit protein complexes to modulate their activities (Aim 3). Ubiquitylation affects many important cellular processes and has been linked to a number of human diseases including cancer, neurodegeneration, and retroviral infection. A contribution of proteolysis-independent ubiquitylation in these diseases is emerging and it will be important to understand the mechanism behind this regulation to design diagnostic tools and treatment strategies. This proposal aims to achieve detailed mechanistic insight into proteolysis-independent ubiquitin signals and to define the concepts of these regulatory ubiquitylation pathways.
描述(由申请人提供):泛素化,即小蛋白泛素与其他蛋白质的共价连接,调节许多细胞过程。蛋白质泛素化 已成为蛋白质降解的同义词,目前的研究大多集中在泛素在靶向蛋白质以被26S蛋白酶体降解中的作用。然而,我们开始意识到,许多蛋白质的泛素化的蛋白水解独立的方式进行调节。最近的系统范围的实验表明,只有略多于百分之五十的泛素化蛋白质被蛋白酶体有效地降解,这意味着蛋白质泛素化具有广泛的信号转导功能的蛋白酶体途径之外。这些蛋白水解无关的泛素信号分子的理解将是重要的基础生物医学研究和治疗靶向泛素系统的发展。一些关键问题是:为什么有些泛素化蛋白质被降解,而另一些则没有?泛素化如何直接影响蛋白质活性?通过泛素化直接调节蛋白质的机制是什么?调节的成分是什么? 我们分析了由cullin-RING泛素连接酶复合物SCFMet30调节的系统,该复合物将代谢应激与细胞周期调节联系起来。该途径特别适合于探测泛素化的非蛋白水解信号,因为相同的连接酶用相同的赖氨酸-48连接的泛素链修饰不同的底物蛋白,然而一些底物被标记为降解,而其他底物以蛋白水解独立的方式被调节。该建议建立在可用于分析该途径的生物化学和生理学的大量工具的基础上,并且将解决(i)受调节的泛素结合结构域如何支配信号身份以及在泛素链信号传导之间切换以进行降解和非蛋白水解调节(Aim 1);(ii)多聚泛素链如何直接调节转录因子活性(Aim 2)和(iii)泛素化如何诱导主动拆卸/重塑多亚基蛋白质复合物以调节其活性(目的3)。 泛素化影响许多重要的细胞过程,并与许多人类疾病,包括癌症,神经变性和逆转录病毒感染有关。这些疾病中的蛋白水解独立的泛素化的贡献正在出现,这将是重要的是要了解这种调节背后的机制,以设计诊断工具和治疗策略。该提案旨在实现详细的机制洞察蛋白水解独立的泛素信号,并定义这些监管泛素化途径的概念。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter Kaiser其他文献

Peter Kaiser的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter Kaiser', 18)}}的其他基金

Mechanisms of mutant p53 reactivation
突变体 p53 重新激活的机制
  • 批准号:
    10719196
  • 财政年份:
    2023
  • 资助金额:
    $ 42.87万
  • 项目类别:
Ubiquitin and Metabolite Signaling
泛素和代谢信号传导
  • 批准号:
    10552304
  • 财政年份:
    2023
  • 资助金额:
    $ 42.87万
  • 项目类别:
Developing corrector small molecules for reactivation of mutant p53 in cancer
开发用于重新激活癌症中突变 p53 的校正小分子
  • 批准号:
    10512976
  • 财政年份:
    2022
  • 资助金额:
    $ 42.87万
  • 项目类别:
Developing corrector small molecules for reactivation of mutant p53 in cancer
开发用于重新激活癌症中突变 p53 的校正小分子
  • 批准号:
    10675004
  • 财政年份:
    2022
  • 资助金额:
    $ 42.87万
  • 项目类别:
Methionine Dependency of Cancer
癌症的蛋氨酸依赖性
  • 批准号:
    9815049
  • 财政年份:
    2019
  • 资助金额:
    $ 42.87万
  • 项目类别:
Methionine Dependency of Cancer
癌症的蛋氨酸依赖性
  • 批准号:
    10016225
  • 财政年份:
    2019
  • 资助金额:
    $ 42.87万
  • 项目类别:
Molecular concepts that monitor methionine metabolism
监测蛋氨酸代谢的分子概念
  • 批准号:
    9892665
  • 财政年份:
    2018
  • 资助金额:
    $ 42.87万
  • 项目类别:
Regulation by Proteolysis-Independent Ubiquitination
不依赖蛋白水解的泛素化调节
  • 批准号:
    7854558
  • 财政年份:
    2009
  • 资助金额:
    $ 42.87万
  • 项目类别:
Identification of Small Molecules for Reactivation of p53 Cancer Mutants
鉴定用于 p53 癌症突变体再激活的小分子
  • 批准号:
    7617518
  • 财政年份:
    2008
  • 资助金额:
    $ 42.87万
  • 项目类别:
REGULATION OF THE TRANSCRIPTION FACTOR MET4
转录因子 MET4 的调节
  • 批准号:
    7602159
  • 财政年份:
    2007
  • 资助金额:
    $ 42.87万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 42.87万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.87万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 42.87万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.87万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 42.87万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.87万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 42.87万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 42.87万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 42.87万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.87万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了